Atlas Effectors of Anti-Tumor Immunity

1. Adoptive immunotherapy for human cancers: Flagmen signal first “open road” then “roadblocks.” A narrative synopsis
Joseph G. Sinkovics

2. Tumor microenvironment genesis and implications on cancer immune response
Gianfranco Baronzio, Isabel Freitas

3. Natural killer cells. Lymphokine-activated killers
Irina Zh. Shubina, Olga V. Lebedinskaya, Evgenia O. Khalturina, Irina O. Chikileva, Mikhail V. Kiselevsky

4. CD4+/CD25+ T-regulatory cells
Irina Zh. Shubina, Nadezhda P. Velizheva, Mikhail V. Kiselevsky

5. CD8+ CD57+ T cells in tumor immunology
María I. Sada-Ovalle

6. Natural killer T (NKT) cells: Immunophenotype, functional characteristics and significance in clinical practice
Olga V. Lebedinskaya, Nelly K. Akchmatova, Irina O. Chikileva, Irina Zh. Shubina, Mikhail V. Kiselevsky

7. LAK immunotherapy in clinical studies
Irina Zh. Shubina, Lev V. Demidov, Irina O. Chikileva, Olga V. Lebedinskaya, Mikhail V. Kiselevsky

8. Major properties of dendritic cells and their actual and potential applications in cancer therapy and infectious disease prophylaxis
Irina O. Chikileva, Natalia Yu. Anisimova, Olga V. Lebedinskaya, Mikhail V. Kiselevsky, Vyacheslav M. Abramov

Avainsanat: Biomedicine, Cancer Research, Immunology, Oncology, Biomedicine general